483 Astellas Pharma Tech Oct 2019

483 Astellas Pharma Tech Oct 2019

Maxwell Van Tassell FDA$119.00 - Available Now

FDA investigators audited the Astellas Pharma Tech - Toyama, Japan facility and issued inspectional observations (via FDA 483) on 08 Oct 2019.

Product details

  • Category: Human Drugs
  • Inspection end: 08 Oct 2019
  • Location: Toyama, Japan
  • FEI: 3002807003
Add To Cart